DIDRONEL Side Effects

6669785-8 | Condition Aggravated, Interstitial Lung Disease, Nervousness, Pulmonary Fibrosis, Reflux Oesophagitis, Throat Irritation
on Mar 19, 2010 Female patient from JAPAN , 76 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Didronel (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, interstitial lung disease, nervousness, pulmonary fibrosis (What is pulmonary fibrosis?), reflux oesophagitis, throat irritation. Didronel dosage: Oral.

6589404-9 | Hypercalcaemia
Patient was taking Didronel (View Usage). Patient had the following side effects: hypercalcaemia on Jan 28, 2010 from JAPAN Additional patient health information: Female patient , 72 years of age, was diagnosed with extraskeletal ossification, hip arthroplasty and. Didronel dosage: 800 Mg, 1/day, Oral.

6529377-8 | Hypercalcaemia
Adverse event was reported on Dec 16, 2009 by a Female patient taking Didronel (View Usage) (Dosage: 800 Mg, 1/day, Oral) was diagnosed with extraskeletal ossification, hip arthroplasty and. Location: JAPAN , 72 years of age, After Didronel was administered, patient had the following side effects: hypercalcaemia.

6508001-4 | Femur Fracture
on Mar 20, 2009 Male patient from UNITED STATES , 39 years of age, was diagnosed with extraskeletal ossification and was treated with Didronel (View Usage). Patient experienced the following unwanted or unexpected effects: femur fracture. Didronel dosage: 1800 Mg Daily, Oral. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ), DOCUSATE (DOCUSATE) (View Docusate (docusate) Review and Docusate (docusate) Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), VESICARE /01735901/ (SOLIFENACIN) (View Vesicare /01735901/ (solifenacin) Review and Vesicare /01735901/ (solifenacin) Label ), SENNA /00142201/ (SENNA ALEXANDRINA) (View Senna /00142201/ (senna Alexandrina) Review and Senna /00142201/ (senna Alexandrina) Label ), DILANTIN /00017401/ (PHENYTOIN) (View Dilantin /00017401/ (phenytoin) Review and Dilantin /00017401/ (phenytoin) Label ). Patient was hospitalized.


6383259-3 | Brachial Plexopathy, Dental Caries, Fistula Discharge, Gingival Swelling, Gingivitis, Haematoma, Jaw Disorder, Leukoplakia Oral, Loose Tooth
on Sep 14, 2009 Female patient from UNITED STATES , 63 years of age, weighting 149.9 lb, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Didronel (View Usage). Patient had the following side effects: brachial plexopathy, dental caries, fistula discharge, gingival swelling, gingivitis, haematoma, jaw disorder, leukoplakia oral, loose tooth. Didronel dosage: 1 Df Daily For 14 Days Every 2 Months, Oral. During the same period patient was treated with ACTONEL (35 Mg Once Weekly, Oral) (View Actonel Review and Actonel Label ), FOSAMAX (10 Mg Once Daily, Oral) (View Fosamax Review and Fosamax Label ), LASIX (View Lasix Review and Lasix Label ), TIGAN (View Tigan Review and Tigan Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), SELDANE (View Seldane Review and Seldane Label ), ORNADE /00014501/ (CHLORPHENAMINE MALEATE, PHENYLPROPANOLAMINE HYDROCH (View Ornade /00014501/ (chlorphenamine Maleate, Phenylpropanolamine Hydroch Review and Ornade /00014501/ (chlorphenamine Maleate, Phenylpropanolamine Hydroch Label ), CLINORIL (View Clinoril Review and Clinoril Label ).

6346737-9 | Small Intestinal Perforation
Patient was taking Didronel (View Usage). After Didronel was administered, patient had the following side effects: small intestinal perforation on Sep 01, 2009 from FRANCE Additional patient health information: Male patient , 67 years of age, . Didronel dosage: Oral. Patient was hospitalized.

6185550-2 | Breast Cancer, Osteolysis, Osteonecrosis, Tooth Disorder
Adverse event was reported on Apr 28, 2009 by a Female patient taking Didronel (View Usage) (Dosage: Oral) was diagnosed with osteoporosis (What is osteoporosis?) and. Location: FRANCE , 76 years of age, Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?), osteolysis, osteonecrosis (What is osteonecrosis?), tooth disorder (What is tooth disorder?). During the same period patient was treated with BONIVA (View Boniva Review and Boniva Label ).

6148938-1 | Ammonia Increased, Arthralgia, Arthropathy, Ascites, Bursitis, C-reactive Protein Increased, Condition Aggravated, Decreased Activity, Femoral Neck Fracture
on Mar 25, 2009 Male patient from JAPAN , 52 years of age, was diagnosed with calcification metastatic, osteoporosis (What is osteoporosis?) and was treated with Didronel (View Usage). Patient had the following side effects: ammonia increased, arthralgia, arthropathy, ascites, bursitis (What is bursitis?), c-reactive protein increased, condition aggravated, decreased activity, femoral neck fracture. Didronel dosage: 200 Mg At Bedtime, Oral. During the same period patient was treated with NEUROVITAN /00176001/ (CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAM (View Neurovitan /00176001/ (cyanocobalamin, Pyridoxine Hydrochloride, Thiam Review and Neurovitan /00176001/ (cyanocobalamin, Pyridoxine Hydrochloride, Thiam Label ). Patient was hospitalized and became disabled.

6131111-0 | Pain In Extremity, Stress Fracture
on Mar 13, 2009 Male patient from UNITED KINGDOM , 83 years of age, was treated with Didronel (View Usage). After Didronel was administered, patient had the following side effects: pain in extremity, stress fracture. Didronel dosage: Oral. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6128781-X | Abdominal Distension, Activated Partial Thromboplastin Time Prolonged, Gastrointestinal Ulcer Haemorrhage, Haematemesis, Haematocrit Decreased, Haemoglobin Decreased, Heart Rate Increased, Hiatus Hernia, Melaena
Patient was taking Didronel (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, activated partial thromboplastin time prolonged, gastrointestinal ulcer haemorrhage, haematemesis, haematocrit decreased, haemoglobin decreased, heart rate increased, hiatus hernia, melaena on Mar 09, 2009 from GERMANY Additional patient health information: Female patient , 69 years of age, weighting 108.0 lb, was diagnosed with osteoporosis (What is osteoporosis?), hepatic cirrhosis and. Didronel dosage: 200 Mg, 1 /day Oral. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (100 Mg 1/day Oral) (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CALCIUM (CALCIUM) (View Calcium (calcium) Review and Calcium (calcium) Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), XIPAMIDE (XIPAMIDE) (View Xipamide (xipamide) Review and Xipamide (xipamide) Label ). Patient was hospitalized.

6128453-1 | Osteonecrosis
Adverse event was reported on Mar 09, 2009 by a Female patient taking Didronel (View Usage) (Dosage: Oral) was diagnosed with osteoporosis (What is osteoporosis?) and. Location: FRANCE , 76 years of age, Patient had the following side effects: osteonecrosis (What is osteonecrosis?). During the same period patient was treated with BONIVA (View Boniva Review and Boniva Label ).

6055754-8 | Dental Pulp Disorder, Gingivitis Ulcerative, Toothache, Vasoconstriction
on Jan 15, 2009 Female patient from FRANCE , 68 years of age, was diagnosed with osteopenia and was treated with Didronel (View Usage). After Didronel was administered, patient had the following side effects: dental pulp disorder, gingivitis ulcerative, toothache, vasoconstriction. Didronel dosage: 400 Mg, Cyclic 1/d, Oral. During the same period patient was treated with ARSENIC (ARSENIC) (Dental) (View Arsenic (arsenic) Review and Arsenic (arsenic) Label ).

5917571-6 | Bone Disorder, Condition Aggravated, Hypophagia, Jaw Disorder, Osteomyelitis, Osteonecrosis, Osteosclerosis, Primary Sequestrum
on Sep 25, 2008 Female patient from JAPAN , 53 years of age, was diagnosed with osteoporosis (What is osteoporosis?), collagen disorder and was treated with Didronel (View Usage). Patient experienced the following unwanted or unexpected effects: bone disorder, condition aggravated, hypophagia, jaw disorder, osteomyelitis, osteonecrosis (What is osteonecrosis?), osteosclerosis, primary sequestrum. Didronel dosage: Oral. During the same period patient was treated with PREDONINE /00016201/ (PREDNISOLONE) (Oral) (View Predonine /00016201/ (prednisolone) Review and Predonine /00016201/ (prednisolone) Label ), VIT K CAP (View Vit K Cap Review and Vit K Cap Label ), ALFAROL (ALFACALCIDOL) (View Alfarol (alfacalcidol) Review and Alfarol (alfacalcidol) Label ), SLOW K (View Slow-k Review and Slow-k Label ), EVOXAC (View Evoxac Review and Evoxac Label ), OPALMON (LIMAPROST) (View Opalmon (limaprost) Review and Opalmon (limaprost) Label ), PRORENAL (LIMAPROST) (View Prorenal (limaprost) Review and Prorenal (limaprost) Label ).

5901379-1 | Activities Of Daily Living Impaired, Ammonia Increased, Arthralgia, Bone Pain, Bursitis, C-reactive Protein Increased, Condition Aggravated, Decreased Activity, Femoral Neck Fracture
Patient was taking Didronel (View Usage). Patient had the following side effects: activities of daily living impaired, ammonia increased, arthralgia, bone pain, bursitis (What is bursitis?), c-reactive protein increased, condition aggravated, decreased activity, femoral neck fracture on Sep 10, 2008 from JAPAN Additional patient health information: Male patient , 52 years of age, was diagnosed with calcification metastatic, osteoporosis (What is osteoporosis?) and. Didronel dosage: 200 Mg At Bedtime, Oral; 200 Mg Daily, Oral. Patient was hospitalized and became disabled.

5874857-1 | Ammonia Increased, Arthralgia, Bone Pain, Bursitis, Decreased Activity, Femoral Neck Fracture, Gait Disturbance, Hypoproteinaemia
Adverse event was reported on Aug 20, 2008 by a Male patient taking Didronel (View Usage) (Dosage: 200 Mg At Bedtime, Oral) was diagnosed with osteoporosis (What is osteoporosis?) and. Location: JAPAN , 52 years of age, After Didronel was administered, patient had the following side effects: ammonia increased, arthralgia, bone pain, bursitis (What is bursitis?), decreased activity, femoral neck fracture, gait disturbance, hypoproteinaemia. During the same period patient was treated with NEUROVITAN (CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCH (View Neurovitan (cyanocobalamin, Pyridoxine Hydrochloride, Thiamine Hydroch Review and Neurovitan (cyanocobalamin, Pyridoxine Hydrochloride, Thiamine Hydroch Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TAURINE (TAURINE) (View Taurine (taurine) Review and Taurine (taurine) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized and became disabled.

5871367-2 | Arthralgia
on Sep 04, 2008 Female patient from UNITED STATES , weighting 128.0 lb, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Didronel (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia. Didronel dosage: 1 Per Day.

5766111-3 | Myocardial Infarction, Pituitary Tumour
on May 21, 2008 Female patient from CANADA , 77 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Didronel (View Usage). Patient had the following side effects: myocardial infarction, pituitary tumour. Didronel dosage: 1 Tablet Cyclic Daily, Oral. During the same period patient was treated with CALCIUM (CALCIUM (View Calcium (calcium Review and Calcium (calcium Label ), ERGOCALCIFEROL (View Ergocalciferol Review and Ergocalciferol Label ), MULTIVITAMIN /00831701/ (VITAMINS NOS) (View Multivitamin /00831701/ (vitamins Nos) Review and Multivitamin /00831701/ (vitamins Nos) Label ). Patient was hospitalized.

5688197-7 | Arthralgia, Calcinosis, Condition Aggravated, Feeling Abnormal, Intermittent Claudication, Osteonecrosis
Patient was taking Didronel (View Usage). After Didronel was administered, patient had the following side effects: arthralgia, calcinosis, condition aggravated, feeling abnormal, intermittent claudication, osteonecrosis (What is osteonecrosis?) on Mar 12, 2008 from JAPAN Additional patient health information: Female patient , 69 years of age, was diagnosed with extraskeletal ossification and. Didronel dosage: 1000 Mg Daily, Oral, 800 Mg, Daily, Oral.

5647119-5 | Cholelithiasis
Adverse event was reported on Feb 19, 2008 by a Female patient taking Didronel (View Usage) (Dosage: 400 Mg, Cyclic 1/d, Oral) was diagnosed with osteopenia and. Location: UNITED KINGDOM , 62 years of age, weighting 183.0 lb, Patient experienced the following unwanted or unexpected effects: cholelithiasis. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

5545666-8 | Cerebrovascular Accident
on Nov 29, 2007 Female patient from UNITED KINGDOM , 88 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Didronel (View Usage). Patient had the following side effects: cerebrovascular accident. Didronel dosage: 1 Talbet, Cyclic 1/d, Oral. Patient was hospitalized and became disabled.

5528422-6 | Dental Alveolar Anomaly, Impaired Healing, Jaw Disorder, Osteonecrosis, Primary Sequestrum, Spinal Fracture
on Nov 07, 2007 Male patient from JAPAN , 78 years of age, was diagnosed with spinal fracture and was treated with Didronel (View Usage). After Didronel was administered, patient had the following side effects: dental alveolar anomaly, impaired healing, jaw disorder, osteonecrosis (What is osteonecrosis?), primary sequestrum, spinal fracture. Didronel dosage: Oral. During the same period patient was treated with RISEDRONATE SODIUM (Oral) (View Risedronate Sodium Review and Risedronate Sodium Label ), BONALON /01220301/(ALENDRONIC ACID) 5MG (5 Mg, Oral) (View Bonalon /01220301/(alendronic Acid) 5mg Review and Bonalon /01220301/(alendronic Acid) 5mg Label ), VIT K CAP (View Vit K Cap Review and Vit K Cap Label ), ALFAROL (ALFACALCIDOL) (View Alfarol (alfacalcidol) Review and Alfarol (alfacalcidol) Label ), SHAKUYAKUKANZOUTOU (HERBAL EXTRACT NOS) (View Shakuyakukanzoutou (herbal Extract Nos) Review and Shakuyakukanzoutou (herbal Extract Nos) Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ENDOXAN /00021101/ (CYCLOPHOSPHAMIDE) (View Endoxan /00021101/ (cyclophosphamide) Review and Endoxan /00021101/ (cyclophosphamide) Label ).

5500157-5 | Bone Disorder, Face Oedema, Fistula, Gingival Disorder, Impaired Healing, Osteitis, Osteonecrosis, Osteosclerosis, Pain In Jaw
Patient was taking Didronel (View Usage). Patient experienced the following unwanted or unexpected effects: bone disorder, face oedema, fistula (What is fistula?), gingival disorder, impaired healing, osteitis, osteonecrosis (What is osteonecrosis?), osteosclerosis, pain in jaw on Aug 07, 2007 from JAPAN Additional patient health information: Female patient , 68 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and. Didronel dosage: 200 Mg Daily (14 Days In 3 Months), Oral. During the same period patient was treated with BONALON /01220301/(ALENDRONIC ACID) 5MG (5 Mg Daily, Oral) (View Bonalon /01220301/(alendronic Acid) 5mg Review and Bonalon /01220301/(alendronic Acid) 5mg Label ), FOSAMAC(ALENDRONATE SODIUM) 5MG (5 Mg Daily, Oral) (View Fosamac(alendronate Sodium) 5mg Review and Fosamac(alendronate Sodium) 5mg Label ), ONE ALPHA (ALFACALCIDOL) (View One-alpha (alfacalcidol) Review and One-alpha (alfacalcidol) Label ).

5455138-7 | Jaw Disorder, Oral Intake Reduced, Osteomyelitis, Osteonecrosis, Osteosclerosis, Primary Sequestrum
Adverse event was reported on Aug 31, 2007 by a Female patient taking Didronel (View Usage) (Dosage: Oral) was diagnosed with osteoporosis (What is osteoporosis?), collagen disorder and. Location: JAPAN , 53 years of age, Patient had the following side effects: jaw disorder, oral intake reduced, osteomyelitis, osteonecrosis (What is osteonecrosis?), osteosclerosis, primary sequestrum. During the same period patient was treated with PREDONINE /00016201/(PREDNISOLONE) (Oral) (View Predonine /00016201/(prednisolone) Review and Predonine /00016201/(prednisolone) Label ), VIT K CAP (View Vit K Cap Review and Vit K Cap Label ), ALFAROL (ALFACALCIDOL) (View Alfarol (alfacalcidol) Review and Alfarol (alfacalcidol) Label ), SLOW K (View Slow-k Review and Slow-k Label ), EVOXAC (View Evoxac Review and Evoxac Label ), OPALMON (LIMAPROST) (View Opalmon (limaprost) Review and Opalmon (limaprost) Label ), PRORENAL (LIMAPROST) (View Prorenal (limaprost) Review and Prorenal (limaprost) Label ).

5446082-X | Condition Aggravated, Osteomyelitis, Resorption Bone Increased
on Aug 24, 2007 Female patient from JAPAN , 53 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Didronel (View Usage). After Didronel was administered, patient had the following side effects: condition aggravated, osteomyelitis, resorption bone increased. Didronel dosage: .

5424806-5 | Bacterial Infection, Bone Pain, Diarrhoea, Hip Arthroplasty, Metastasis, Mouth Ulceration, Neutropenia, Osteonecrosis
on Aug 03, 2007 Female patient from UNITED STATES , 62 years of age, was treated with Didronel (View Usage). Patient experienced the following unwanted or unexpected effects: bacterial infection (What is bacterial infection?), bone pain, diarrhoea, hip arthroplasty, metastasis, mouth ulceration, neutropenia, osteonecrosis (What is osteonecrosis?). Didronel dosage: Oral. During the same period patient was treated with PAMIDRONATE DISODIUM (90 Mg Over 1.5-2 Hours Monthly, Iv Nos) (View Pamidronate Disodium Review and Pamidronate Disodium Label ), RADIOTREATMENT () (View Radiotreatment () Review and Radiotreatment () Label ), GOSERELIN (GOSERELIN) (View Goserelin (goserelin) Review and Goserelin (goserelin) Label ), MEGESTROL ACETATE (View Megestrol Acetate Review and Megestrol Acetate Label ), CYCLOPHOSPHAMID W/DOXORUBICIN (CYCLOPHOSPHAMIDE, DOXORUBICIN) (View Cyclophosphamid W/doxorubicin (cyclophosphamide, Doxorubicin) Review and Cyclophosphamid W/doxorubicin (cyclophosphamide, Doxorubicin) Label ), 5 FLUOROURACIL /00098801/ (FLUOROURACIL) (View 5-fluorouracil /00098801/ (fluorouracil) Review and 5-fluorouracil /00098801/ (fluorouracil) Label ).

5391760-4 | Dental Fistula, Osteomyelitis, Post Procedural Complication, Primary Sequestrum, Purulent Discharge, Swelling Face, Tooth Extraction
Patient was taking Didronel (View Usage). Patient had the following side effects: dental fistula, osteomyelitis, post procedural complication, primary sequestrum, purulent discharge, swelling face, tooth extraction on Jul 02, 2007 from JAPAN Additional patient health information: Female patient , 79 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and. Didronel dosage: 200 Mg, Cyclic 14 Days On 3 Months Off, Oral. During the same period patient was treated with FERROMIA (FERROUS CITRATE) (View Ferromia (ferrous Citrate) Review and Ferromia (ferrous Citrate) Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), KELNAC (PLAUNOTOL) (View Kelnac (plaunotol) Review and Kelnac (plaunotol) Label ).

5332868-9 | Neuropathy Peripheral
Adverse event was reported on May 16, 2007 by a Female patient taking Didronel (View Usage) (Dosage: 400 Mg, Oral) was diagnosed with osteoporosis (What is osteoporosis?) and. Location: UNITED KINGDOM , 66 years of age, weighting 176.4 lb, After Didronel was administered, patient had the following side effects: neuropathy peripheral. During the same period patient was treated with ACTONEL (View Actonel Review and Actonel Label ).

5217022-3 | Phlebitis, Pulmonary Embolism
on Jan 12, 2007 Female patient from FRANCE , 62 years of age, weighting 176.4 lb, was treated with Didronel (View Usage). Patient experienced the following unwanted or unexpected effects: phlebitis, pulmonary embolism (What is pulmonary embolism?). Didronel dosage: 400 Mg, Daily, Oral. During the same period patient was treated with PREVISCAN(FLUINDIONE) TABLET, 20MG (15 Mg, Daily, Oral) (View Previscan(fluindione) Tablet, 20mg Review and Previscan(fluindione) Tablet, 20mg Label ), IDARAC (200 Mg, 4/day, Oral) (View Idarac Review and Idarac Label ), VALSARTAN (30 Mg, Daily, Oral) (View Valsartan Review and Valsartan Label ), ENDOTELON /00811401/(VITIS VINIFERA, HERBAL EXTRACT NOS) (150 Mg, 2/day, Oral) (View Endotelon /00811401/(vitis Vinifera, Herbal Extract Nos) Review and Endotelon /00811401/(vitis Vinifera, Herbal Extract Nos) Label ), OROCAL /00108001/(CALCIUM CARBONATE) (1 Tablet, Daily Oral) (View Orocal /00108001/(calcium Carbonate) Review and Orocal /00108001/(calcium Carbonate) Label ). Patient was hospitalized.

5199432-6 | Alopecia, Asthenia, Conjunctival Haemorrhage, Dyspnoea, Headache, Nausea
on Dec 19, 2006 Female patient from UNITED STATES , 65 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Didronel (View Usage). Patient had the following side effects: alopecia, asthenia, conjunctival haemorrhage, dyspnoea, headache (What is headache?), nausea (What is nausea?). Didronel dosage: 400 Mg Cyclic, Oral. During the same period patient was treated with EVISTA (View Evista Review and Evista Label ), THYROID HORMONES (View Thyroid Hormones Review and Thyroid Hormones Label ), BIOTIN (View Biotin Review and Biotin Label ).

5196376-0 | Cerebrovascular Accident
Patient was taking Didronel (View Usage). After Didronel was administered, patient had the following side effects: cerebrovascular accident on Dec 12, 2006 from UNITED KINGDOM Additional patient health information: Male patient , 78 years of age, . Didronel dosage: .

5159313-0 | Gastric Ulcer, Haematochezia, Haemoglobin Decreased, Lethargy, Melaena
Adverse event was reported on Nov 07, 2006 by a Female patient taking Didronel (View Usage) (Dosage: Oral) . Location: UNITED KINGDOM , 82 years of age, Patient experienced the following unwanted or unexpected effects: gastric ulcer, haematochezia, haemoglobin decreased, lethargy, melaena. During the same period patient was treated with ASPIRIN (Iv Nos) (View Aspirin Review and Aspirin Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), DOSULEPIN (DOSULEPIN) (View Dosulepin (dosulepin) Review and Dosulepin (dosulepin) Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SENNA (SENNA ALEXANDRINA) (View Senna (senna Alexandrina) Review and Senna (senna Alexandrina) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

5151000-8 | Tooth Resorption
on Oct 30, 2006 Female patient from UNITED KINGDOM , 77 years of age, was diagnosed with osteopenia and was treated with Didronel (View Usage). Patient had the following side effects: tooth resorption. Didronel dosage: 1 Tablet, Cyclic 1/d, Oral. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).

5087204-2 | Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Carcinoembryonic Antigen Increased, Thrombocytopenia
on Aug 08, 2006 Female patient from JAPAN , 68 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Didronel (View Usage). After Didronel was administered, patient had the following side effects: blood lactate dehydrogenase increased, c-reactive protein increased, carcinoembryonic antigen increased, thrombocytopenia. Didronel dosage: 200 Mg, Oral. During the same period patient was treated with ADALAT (View Adalat Review and Adalat Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), LIPITOR (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

5075004-9 | Dental Examination Abnormal, Jaw Disorder, Osteonecrosis, Tooth Discolouration, Tooth Extraction
Patient was taking Didronel (View Usage). Patient experienced the following unwanted or unexpected effects: dental examination abnormal, jaw disorder, osteonecrosis (What is osteonecrosis?), tooth discolouration, tooth extraction on Jul 28, 2006 from UNITED STATES Additional patient health information: Female patient , 53 years of age, weighting 84.00 lb, was diagnosed with osteoporosis (What is osteoporosis?) and. Didronel dosage: 400 Mg Daily, Oral. During the same period patient was treated with ACTONEL (35 Mg Once Weekly, Oral) (View Actonel Review and Actonel Label ), FOSAMAX (10 Mg Daily, Oral) (View Fosamax Review and Fosamax Label ), PERIDEX (CHLORHEXIDINE GLUCONATE) SOLUTION (View Peridex (chlorhexidine Gluconate) Solution Review and Peridex (chlorhexidine Gluconate) Solution Label ), LIDODERM (LIDOCAINE) PATCH (View Lidoderm (lidocaine) Patch Review and Lidoderm (lidocaine) Patch Label ), NYSTATIN (NYSTATIN) LIQUID (View Nystatin (nystatin) Liquid Review and Nystatin (nystatin) Liquid Label ), PERI COLACE (DOCUSATE SODIUM, CASANTHRANOL) TABLET (View Peri-colace (docusate Sodium, Casanthranol) Tablet Review and Peri-colace (docusate Sodium, Casanthranol) Tablet Label ), FERROUS SULFATE (FERROUS SULFATE) TABLET (View Ferrous Sulfate (ferrous Sulfate) Tablet Review and Ferrous Sulfate (ferrous Sulfate) Tablet Label ). Patient was hospitalized and became disabled.

5047196-9 | Fall, Pelvic Fracture
Adverse event was reported on Jun 22, 2006 by a Female patient taking Didronel (View Usage) (Dosage: Oral) was diagnosed with osteoporosis (What is osteoporosis?) and. Location: FRANCE , 92 years of age, Patient had the following side effects: fall (What is fall?), pelvic fracture. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MOTILIUM (View Motilium Review and Motilium Label ), SERECOR (HYDROQUINIDINE HYDROCHLORIDE) (View Serecor (hydroquinidine Hydrochloride) Review and Serecor (hydroquinidine Hydrochloride) Label ), CORVASAL (MOLSIDOMINE) (View Corvasal (molsidomine) Review and Corvasal (molsidomine) Label ). Patient was hospitalized.

5043228-2 | Haematemesis, Nausea, Ulcer
on Jun 19, 2006 Female patient from UNITED KINGDOM , 83 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Didronel (View Usage). After Didronel was administered, patient had the following side effects: haematemesis, nausea (What is nausea?), ulcer (What is ulcer?). Didronel dosage: 1 Tablet, Daily, Oral. During the same period patient was treated with BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), OMACOR (OMEGA 3 MARINE TRIGLYCERIDES) (View Omacor (omega-3 Marine Triglycerides) Review and Omacor (omega-3 Marine Triglycerides) Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

5009619-0 | Antinuclear Antibody Positive, Blood Carbon Monoxide Decreased, Crepitations, Lung Neoplasm, Pulmonary Fibrosis, Raynaud's Phenomenon
on May 12, 2006 Female patient from UNITED STATES , 76 years of age, weighting 155.9 lb, was diagnosed with osteoporosis prophylaxis and was treated with Didronel (View Usage). Patient experienced the following unwanted or unexpected effects: antinuclear antibody positive, blood carbon monoxide decreased, crepitations, lung neoplasm, pulmonary fibrosis (What is pulmonary fibrosis?), raynaud's phenomenon. Didronel dosage: 400 Mg Daily For 2 Weeks Every 3 Months, Oral. During the same period patient was treated with CALCIUM WITH VITAMIN D (CALCIUM PHOSPHATE, CALCIUM SODIUM LACTATE, ERG (View Calcium With Vitamin D (calcium Phosphate, Calcium Sodium Lactate, Erg Review and Calcium With Vitamin D (calcium Phosphate, Calcium Sodium Lactate, Erg Label ), MULTI VIT (VITAMINS NOS) (View Multi-vit (vitamins Nos) Review and Multi-vit (vitamins Nos) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), Z PAK (AZITHROMYCIN) (View Z-pak (azithromycin) Review and Z-pak (azithromycin) Label ), CEFZIL (View Cefzil Review and Cefzil Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

4999326-2 | Pulmonary Fibrosis
Patient was taking Didronel (View Usage). Patient had the following side effects: pulmonary fibrosis (What is pulmonary fibrosis?) on May 01, 2006 from UNITED STATES Additional patient health information: Female patient , 76 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and. Didronel dosage: 400 Mg Daily For 2 Weeks Every 3 Months, Oral.

4976083-7 | Diarrhoea, Gastroenteritis Escherichia Coli, Urinary Tract Infection
Adverse event was reported on Apr 07, 2006 by a Female patient taking Didronel (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , 73 years of age, After Didronel was administered, patient had the following side effects: diarrhoea, gastroenteritis escherichia coli, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with HUMIRA (40 Mg, Every 2wk) (View Humira Review and Humira Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), TENORETIC 100 (View Tenoretic 100 Review and Tenoretic 100 Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ARTHROTEC (View Arthrotec Review and Arthrotec Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

4816431-1 | Blood Immunoglobulin G Increased, Bone Marrow Failure, Eosinophil Count Increased, Haemorrhage Subcutaneous, Helicobacter Pylori Identification Test Positive, Idiopathic Thrombocytopenic Purpura, Pruritus, Red Blood Cell Count Increased, White Blood Cell Count Increased
on Oct 13, 2005 Female patient from JAPAN , 70 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Didronel (View Usage). Patient experienced the following unwanted or unexpected effects: blood immunoglobulin g increased, bone marrow failure, eosinophil count increased, haemorrhage subcutaneous, helicobacter pylori identification test positive, idiopathic thrombocytopenic purpura, pruritus, red blood cell count increased, white blood cell count increased. Didronel dosage: 200 Mg Daily; Oral. During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), PABLON 1 (PARACETAMOL, METHYLEPHEDRINE HYDROCHLORIDE DL, GUAIFENESIN, (View Pablon-1 (paracetamol, Methylephedrine Hydrochloride-dl, Guaifenesin, Review and Pablon-1 (paracetamol, Methylephedrine Hydrochloride-dl, Guaifenesin, Label ). Patient was hospitalized.

4785407-5 | Platelet Count Decreased
on Sep 21, 2005 Female patient from JAPAN , 72 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Didronel (View Usage). Patient had the following side effects: platelet count decreased. Didronel dosage: Oral. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

4716454-7 | Abdominal Pain, Endometriosis, Vesicoureteral Reflux Surgery
Patient was taking Didronel (View Usage). After Didronel was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), endometriosis (What is endometriosis?), vesicoureteral reflux surgery on Jul 07, 2005 from UNITED KINGDOM Additional patient health information: Female patient , 55 years of age, was diagnosed with osteopenia and. Didronel dosage: . During the same period patient was treated with HORMONES AND RELATED AGENTS (View Hormones And Related Agents Review and Hormones And Related Agents Label ), OSTEOCARE (CALCIUM, MAGNESIUM, ZINC, COLECALCIFEROL) (View Osteocare (calcium, Magnesium, Zinc, Colecalciferol) Review and Osteocare (calcium, Magnesium, Zinc, Colecalciferol) Label ). Patient was hospitalized.

4710607-X | Abdominal Pain Upper, Aspartate Aminotransferase Increased, Back Pain, Blood Alkaline Phosphatase Increased, Chest Pain, Effusion, Gamma-glutamyltransferase Increased, Gastric Ulcer Haemorrhage, Oesophageal Ulcer
Adverse event was reported on Jun 24, 2005 by a Female patient taking Didronel (View Usage) (Dosage: 200 Mg, Cyclic Daily, Oral) was diagnosed with osteoporosis (What is osteoporosis?) and. Location: JAPAN , 69 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, aspartate aminotransferase increased, back pain (What is back pain?), blood alkaline phosphatase increased, chest pain (What is chest pain?), effusion, gamma-glutamyltransferase increased, gastric ulcer haemorrhage, oesophageal ulcer. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), NU LOTAN (LOSARTAN POTASSIUM) (View Nu-lotan (losartan Potassium) Review and Nu-lotan (losartan Potassium) Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), SERUMLIPIDREDUCING AGENTS (View Serumlipidreducing Agents Review and Serumlipidreducing Agents Label ). Patient was hospitalized.

4704699-1 | Blood Calcium Decreased, Blood Creatine Phosphokinase Increased, Blood Urea Increased, Cholangitis, Cholelithiasis, Cytomegalovirus Hepatitis, Epstein-barr Virus Antigen Positive, Hepatic Function Abnormal
on Jun 21, 2005 Female patient from , 81 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Didronel (View Usage). Patient had the following side effects: blood calcium decreased, blood creatine phosphokinase increased, blood urea increased, cholangitis, cholelithiasis, cytomegalovirus hepatitis, epstein-barr virus antigen positive, hepatic function abnormal. Didronel dosage: 200 Mg Daily, Oral. Patient was hospitalized.

4699860-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Calcium Decreased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Blood Urea Increased, Body Temperature Increased, C-reactive Protein Increased
on Jun 10, 2005 Female patient from , 81 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Didronel (View Usage). After Didronel was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood calcium decreased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, blood urea increased, body temperature increased, c-reactive protein increased. Didronel dosage: 200 Mg Daily, Oral.

4691093-5 | Back Pain, Chest Pain, Gastric Ulcer Haemorrhage, Oesophageal Ulcer, Sensation Of Foreign Body
Patient was taking Didronel (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), chest pain (What is chest pain?), gastric ulcer haemorrhage, oesophageal ulcer, sensation of foreign body on May 27, 2005 from Additional patient health information: Female patient , 69 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and. Didronel dosage: 200 Mg, Cyclic Daily, Oral. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), NU LOTAN (LOSARTAN POTASSIUM) (View Nu-lotan (losartan Potassium) Review and Nu-lotan (losartan Potassium) Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), SERUM LIPID REDUCING AGENTS (View Serum Lipid Reducing Agents Review and Serum Lipid Reducing Agents Label ). Patient was hospitalized.

4691085-6 | Aseptic Necrosis Bone, Aspergillosis, Renal Failure
Adverse event was reported on Jun 02, 2005 by a Male patient taking Didronel (View Usage) (Dosage: Oral) was diagnosed with osteoporosis (What is osteoporosis?) and. Location: , 52 years of age, Patient had the following side effects: aseptic necrosis bone, aspergillosis, renal failure. During the same period patient was treated with STAGID (METFORMIN EMBONATE) (View Stagid (metformin Embonate) Review and Stagid (metformin Embonate) Label ), COVERSYL (PERINDOPRIL) (View Coversyl (perindopril) Review and Coversyl (perindopril) Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LASIX (View Lasix Review and Lasix Label ), FLIXOTIDE DISKUS (FLUTICASONE PROPIONATE) (View Flixotide Diskus (fluticasone Propionate) Review and Flixotide Diskus (fluticasone Propionate) Label ). Patient was hospitalized.

4685704-8 | Hepatic Function Abnormal
on May 26, 2005 Female patient from , 86 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Didronel (View Usage). After Didronel was administered, patient had the following side effects: hepatic function abnormal. Didronel dosage: 200 Mg Daily, Oral.

4678136-X | Gastric Ulcer Haemorrhage, Oesophageal Ulcer
on May 18, 2005 Female patient from , 69 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Didronel (View Usage). Patient experienced the following unwanted or unexpected effects: gastric ulcer haemorrhage, oesophageal ulcer. Didronel dosage: 200 Mg , Oral. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROVERA IMEDROXYPROGESTERONE ACETATE) (View Provera Imedroxyprogesterone Acetate) Review and Provera Imedroxyprogesterone Acetate) Label ), NU LOTAN (LOSARTAN POTASSIUM) (View Nu-lotan (losartan Potassium) Review and Nu-lotan (losartan Potassium) Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), SERUMLIPIDREDUCING AGENTS (View Serumlipidreducing Agents Review and Serumlipidreducing Agents Label ). Patient was hospitalized.

4672815-6 | Breast Mass, Headache
Patient was taking Didronel (View Usage). Patient had the following side effects: breast mass, headache (What is headache?) on May 12, 2005 from Additional patient health information: Female patient , 68 years of age, was diagnosed with osteoporosis prophylaxis and. Didronel dosage: 0. During the same period patient was treated with CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ).